These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9445175)

  • 21. Targeting the use of platelet IIb/IIIa inhibitors: treatment of acute myocardial infarction.
    Lincoff AM
    Rev Cardiovasc Med; 2002; 3 Suppl 1():S13-9. PubMed ID: 12439432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacological reperfusion in acute myocardial infarct].
    Lorenzoni R; Gensini GF; De Caterina R
    G Ital Cardiol; 1998 Dec; 28(12):1441-55. PubMed ID: 9887401
    [No Abstract]   [Full Text] [Related]  

  • 23. Primary coronary intervention in acute myocardial infarction.
    Kim CX; Davidson CJ
    Ital Heart J; 2004 Jun; 5 Suppl 6():76S-82S. PubMed ID: 15185919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Logic and logistics: conundrum in reperfusion treatment for acute myocardial infarction.
    Brener S; Topol EJ
    Heart; 1999 Oct; 82(4):402-3. PubMed ID: 10490544
    [No Abstract]   [Full Text] [Related]  

  • 25. Reperfusion synergism: will it be both sustained and safe?
    Armstrong PW
    Eur Heart J; 2000 Dec; 21(23):1913-6. PubMed ID: 11071795
    [No Abstract]   [Full Text] [Related]  

  • 26. ASSENT-3: implications for future trial design and clinical practice.
    Van de Werf F
    Eur Heart J; 2002 Jun; 23(12):911-2. PubMed ID: 12069439
    [No Abstract]   [Full Text] [Related]  

  • 27. [Management of acute myocardial infarction. How improve primary angioplasty?].
    Commeau P
    Presse Med; 2011 Jun; 40(6):606-10. PubMed ID: 21498034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Narrative review: reperfusion strategies for ST-segment elevation myocardial infarction.
    Ting HH; Yang EH; Rihal CS
    Ann Intern Med; 2006 Oct; 145(8):610-7. PubMed ID: 17043342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving reperfusion after myocardial infarction.
    Menown IB; Adgey AA
    BMJ; 1999 Dec; 319(7224):1513-5. PubMed ID: 10591692
    [No Abstract]   [Full Text] [Related]  

  • 30. Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI.
    Otterstad JE; Brosstad F
    Scand Cardiovasc J; 2004 Mar; 38(1):9-15. PubMed ID: 15204241
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trial.
    Russo JJ; Goodman SG; Cantor WJ; Fitchett D; Heffernan M; Borgundvaag B; Ducas J; Cohen EA; Džavik V; Mehta SR; Buller CE; Yan AT;
    Heart; 2014 Jun; 100(11):873-80. PubMed ID: 24449716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinolysis for acute myocardial infarction: the future is here and now.
    Armstrong PW; Collen D; Antman E
    Circulation; 2003 May; 107(20):2533-7. PubMed ID: 12777317
    [No Abstract]   [Full Text] [Related]  

  • 33. Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1.
    Armstrong PW; Collen D
    Circulation; 2001 Jun; 103(23):2862-6. PubMed ID: 11401946
    [No Abstract]   [Full Text] [Related]  

  • 34. Reperfusion therapy for acute myocardial infarction: drugs or devices? Is this the right question?
    Pavlides GS; Cokkinos DV
    Clin Cardiol; 2004 May; 27(5):254-6. PubMed ID: 15188937
    [No Abstract]   [Full Text] [Related]  

  • 35. [DC shock and reperfusion in myocardial infarction with ST-segment elevation a hypothesis to be verified].
    Pezza B
    G Ital Cardiol (Rome); 2010 Mar; 11(3):261. PubMed ID: 20550069
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of glycoprotein IIb/IIIa-receptor inhibitors in managing ST-segment-elevation myocardial infarction.
    Racine E
    Am J Health Syst Pharm; 2002 Nov; 59(21 Suppl 7):S27-36. PubMed ID: 12434712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological facilitation of coronary intervention in ST-segment elevation myocardial infarction: time is of the essence.
    Gersh BJ; Stone GW
    JACC Cardiovasc Interv; 2010 Dec; 3(12):1292-4. PubMed ID: 21232724
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacologic reperfusion therapy for acute myocardial infarction.
    Lowe HC; Neill BD; Van de Werf F; Jang IK
    J Thromb Thrombolysis; 2002 Dec; 14(3):179-96. PubMed ID: 12913398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction.
    Neumann FJ; Blasini R; Schmitt C; Alt E; Dirschinger J; Gawaz M; Kastrati A; Schömig A
    Circulation; 1998 Dec; 98(24):2695-701. PubMed ID: 9851955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct thrombin inhibitors (part 2 of 2).
    Arora UK; Dhir M
    J Invasive Cardiol; 2005 Feb; 17(2):85-91. PubMed ID: 15687531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.